Breaking News, Promotions & Moves

Pfizer Names New CEO

Albert Bourla to succeed Ian Read

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

 Dr. Albert Bourla Dr. Albert Bourla, Pfizer’s chief operating officer has been appointed to succeed Ian Read as chief executive officer, effective January 1, 2019. Ian Read will transition from his current role as chairman and CEO to executive chairman of Pfizer’s Board of Directors.   Mr. Read was named CEO in December of 2010 and chairman of the board in December of the following year. Under Mr. Read, Pfizer received 30 FDA approvals and amassed a pipeline with the potential for approximat...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters